# Remimazolam and Emergence Delirium in Pediatrics

> **NCT07046364** · PHASE4 · RECRUITING · sponsor: **Peking University First Hospital** · enrollment: 248 (estimated)

## Conditions studied

- Pediatric
- Neurosurgery
- Sevoflurane Anesthesia
- Remimazolam
- Emergence Delirium

## Interventions

- **DRUG:** Remimazolam
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT07046364
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2027-01-01
- **Final completion:** 2027-01-01
- **Target enrollment:** 248 (ESTIMATED)
- **Last updated:** 2025-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07046364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07046364, "Remimazolam and Emergence Delirium in Pediatrics". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT07046364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*